Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Short term Debt: 2013-2025

Historic Short term Debt for Phibro Animal Health (PAHC) over the last 12 years, with Sep 2025 value amounting to $18.4 million.

  • Phibro Animal Health's Short term Debt rose 145.92% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 million, marking a year-over-year increase of 145.92%. This contributed to the annual value of $16.2 million for FY2025, which is 45.46% down from last year.
  • Per Phibro Animal Health's latest filing, its Short term Debt stood at $18.4 million for Q3 2025, which was up 13.50% from $16.2 million recorded in Q2 2025.
  • Phibro Animal Health's 5-year Short term Debt high stood at $29.8 million for Q1 2024, and its period low was $7.5 million during Q3 2024.
  • In the last 3 years, Phibro Animal Health's Short term Debt had a median value of $18.4 million in 2025 and averaged $20.2 million.
  • Per our database at Business Quant, Phibro Animal Health's Short term Debt crashed by 68.94% in 2024 and then soared by 145.92% in 2025.
  • Quarterly analysis of 5 years shows Phibro Animal Health's Short term Debt stood at $13.1 million in 2021, then grew by 17.49% to $15.4 million in 2022, then skyrocketed by 68.90% to $26.0 million in 2023, then slumped by 37.61% to $16.2 million in 2024, then surged by 145.92% to $18.4 million in 2025.
  • Its last three reported values are $18.4 million in Q3 2025, $16.2 million for Q2 2025, and $16.2 million during Q1 2025.